Previously, Eliquis was only approved to reduce the risk of stroke and blood clots for patients with atrial fibrilliation not caused by a heart valve problem.
More Articles on FDA Approvals:
FDA Approves Migraine ‘Headband’ for Marketing
FDA Approves Myalept to Treat Lipodystrophy Complications
Medtronic Receives FDA 510(k) Clearance for Reveal LINQ Insertable Cardiac Monitor
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.